Flavones-bound in benzodiazepine site on GABA(A) r... - BV FAPESP
Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Flavones-bound in benzodiazepine site on GABA(A) receptor: Concomitant anxiolytic-like and cognitive-enhancing effects produced by Isovitexin and 6-C-glycoside-Diosmetin

Full text
Author(s):
de Oliveira, Daniela Rodrigues [1, 2, 3] ; Todo, Andreia Hatsue [4] ; Rego, Gizelda Maia [5] ; Cerutti, Janete Maria [1] ; Cavalheiro, Alberto Jose [6] ; Galasse Rando, Daniela Goncales [4] ; Cerutti, Suzete Maria [2]
Total Authors: 7
Affiliation:
[1] Univ Fed Sao Paulo, Dept Morfol & Genet, Lab Bases Genet Tumor Tiroide, Sao Paulo, SP - Brazil
[2] Univ Fed Sao Paulo, Dept Ciencias Biol, Lab Farmacol Celular & Comportamental, Diadema, SP - Brazil
[3] Univ Fed Sao Paulo, Dept Patol, Sao Paulo, SP - Brazil
[4] Univ Fed Sao Paulo, Dept Pharmaceut Sci, Med Chem Res Grp, Diadema, SP - Brazil
[5] Brazilian Agr Res Corp EMBRAPA, Dept Forestry Colombo, Colombo, Parana - Brazil
[6] Sao Paulo State Univ, Nuclei Bioassay Biosynth & Ecophysiol Nat Prod Nu, UNESP, Araraquara, SP - Brazil
Total Affiliations: 6
Document type: Journal article
Source: European Journal of Pharmacology; v. 831, p. 77-86, JUL 15 2018.
Web of Science Citations: 3
Abstract

Increasing evidence suggests that flavones can modulate memory and anxiety-like behaviour. However, these therapeutic effects are inconsistent and induce of adverse effects, which have been associated with interactions at the Benzodiazepine (BZ)-binding site. To improve our understanding of flavone effects on memory and anxiety, we employed a plus-maze discriminative avoidance task. Furthermore, we evaluated the potential of the compounds in modulating GABAA receptors via BZ-binding site using molecular modelling studies. Adult male Wistar rats were treated 30 min before training session with Vicenin-2 (0.1 and 0.25 mg/kg), Vitexin (0.1 and 0.25 mg/kg), Isovitexin (0.1 and 0.25 mg/kg) and 0.1 mg/ kg 6-C-glycoside-Diosmetin, vehicle and a GABAA receptor agonist. The analysis of the time spent in the non-aversive vs aversive enclosed arms during the test session and percentage of time in the open arms within the training session revealed that treatment with Isovitexin and 6-C-glycoside-Diosmetin had memory-enhancing and anxiolytic-like effects (P < 0.001). In contrast, treatment with a higher dose of Diazepam impaired short- and long-term memory when it alleviated anxiety level. Docking studies revealed that flavones docked in a very similar way to that observed to the Diazepam, except by a lack of interaction in residue alpha 1His101 in the BZ-binding site on GABAA receptors, which may be related to memory-enhancing effect. The occurrence of the alpha 1His101 interaction could justify the memory-impairing observed following Diazepam treatment. These findings provide the first evidence that Isovitexin and 6-C-glycoside-Diosmetin could exert their memory-enhancing and anxiolytic-like effects via GABAA receptor modulation, which likely occurs via their benzodiazepine-binding site. (AU)

FAPESP's process: 09/15229-8 - Expression of glutamatergic, serotoninergic and GABAergic receptors in the amygdala, hippocampus and prefrontal cortex of rats after acquisition and extinction of fear conditioning: potential therapeutic targets of the standardized extract of Ginkgo biloba
Grantee:Suzete Maria Cerutti
Support Opportunities: Regular Research Grants
FAPESP's process: 13/01875-0 - Parallel synthesis, in vitro screening and SAR studies of a nitroderivatives compounds library active against macrophage's pathogens: Mycobacterium tuberculosis NRP forms and Leishmania sp
Grantee:Daniela Goncales Galasse Rando
Support Opportunities: Regular Research Grants